2018 American Transplant Congress
Post-Hoc Analysis of Everolimus Trough Levels around the Onset of Related Adverse Events and Treatment Discontinuation in De Novo Kidney Transplant Recipients from the US92 Study
1US92 Study Group, Salt Lake City; 2Novartis Pharmaceutical Corporation, East Hanover.
Purpose: Around 30%-50% of kidney transplant recipients (KTR) on sirolimus discontinue treatment due to drug-related adverse events (AE) and ~23% on everolimus (EVR) discontinue treatment…2018 American Transplant Congress
Evanescent Antibodies: A Report on the Natural History of Anti-Blood Group A2 Antibodies and Their Rapid Resolution in Patients Awaiting A2 to B Transplantation
Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC.
Introduction: Despite the benefits of A2 to B transplants, centers have been reluctant to adopt such a program due to unanswered questions including whether elevation…2018 American Transplant Congress
State of the Union: Outcomes of a Single Center's A2-to-B Transplants Two Years after the Implementation of KAS
Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC.
Introduction. Since the implementation of the new KAS there are few reports on both single center outcomes in the modern era of transplantation and the…2018 American Transplant Congress
Impact of Immunogenicity on Kidney Allograft Survival in Patients Treated with Induction Therapy
Background. The induction therapy is currently used in the majority of kidney transplant recipients, regardless of their level of donor/recipient compatibility. We examined whether lower…2018 American Transplant Congress
The Impact of Marginal Factors on Postoperative Kidney Function of Complex Living Donors for Kidney Transplantation
Transplant and Endocrine Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan.
BackgroundRecently, complex living donors with marginal factors including hypertension, dyslipidemia, glucose intolerance, and obesity are increasing. Postoperative kidney function of living donors for kidney transplantation…2018 American Transplant Congress
Non-Medical Factors Predict Receipt and Type of Kidney Transplant
African Americans have a higher incidence of end-stage kidney disease but lower rates of both deceased and living donor kidney transplant (DDKT and LDKT) compared…2018 American Transplant Congress
Cognitive Function and Health Literacy Assessment Outcomes in the First Months after Renal Transplant in a Diverse Single Center Population
A renal transplant recipient's (RTR's) abilities to understand and implement medication education are very dependent on cognitive function and health literacy. The purpose of this…2018 American Transplant Congress
Promoting Medication Adherence from the Perspectives of Teen and Young Adult Kidney Recipients, Parents and Health Care Professionals
1University of Pittsburgh, Pittsburgh, PA; 2MUHC, McGill, Montreal, QC, Canada.
Purpose: The Teen Adherence in KidnEy Transplant – Improving Tracking to Optimize Outcomes (TAKE-IT TOO) study was designed to adapt the efficacious Take-IT intervention for…2018 American Transplant Congress
Using Distal Abdominal Aorta as an Outflow Tract for En Bloc Kidney Transplantation from Infant Donors with Extremely Low Body Weight
Pediatric kidney donors are underutilized due to high risk of postoperative thrombosis and other complications. To address these problems, we develop a novel en bloc…2018 American Transplant Congress
Role of Calcium/Calmodulin Kinase IV on Podocyte Function in Transplant Glomerulopathy
Beth Israel Deaconess Medical Center, Boston.
Background : Transplant glomerulopathy(TG) a histological manifestation of chronic antibody mediated rejection and a major cause of late allograft loss. It is well accepted that…
- « Previous Page
- 1
- …
- 256
- 257
- 258
- 259
- 260
- …
- 531
- Next Page »